During the 2017 BIO-Europe partnering meeting in Berlin, Germany, Syncona's Iraj Ali talks to Informa Pharma Intelligence’s Mike Ward about the investment group’s funding sweet spots.
Syncona Focuses On Creating Commercially Ambitious Businesses
With £1bn under management, patient capital company Syncona Limited reveals its strategy for creating and building companies that will generate reimbursable products for patients.
